Biolinq raked in $58 million in capital this week. The company is developing a wearable patch that uses electrochemical sensors to measure a person’s glucose levels from the intradermal space just beneath the surface of their skin.
Designed long before the Covid-19 pandemic, Philips received FDA clearance for a wearable sensor that can track respiratory rate. The disposable patch is used to monitor patients after they are moved from the ICU to another care setting.
Zelis CEO Amanda Eisel shares her perspective on how the company is solving the problems of a fragmented health financial system to benefit all.